Outside of the United States?
"Vaccinated?"
Had COVID?
Apprehensive about Shedding?
Obtain a Consultation
Our team has solved refractory health problems for people outside of the United States long before COVID or the jab. Biomarkers are important to provide objectivity to your health issues. However, through our 20+ years of testing, we are now able to understand your risks and underlying causes of health issues with our comprehensive survey. Here is what you can expect.
- 120+ question comprehensive risk survey that includes a detailed color-coded report.
- Review of any labs you have obtained. We put your lab data through our rigorous AI-driven lab data evaluator. You do not need to obtain labs through our program.
- Health consult with Dr. Lewis or other provider on our team.
- Detailed plan.
- Health coaching to answer questions and customize the plan to your life needs.
- All interactions are conducted through Zoom, phone, or other acceptable options.
- In some instances we are able to refer you to a provider in our network not residing in the U.S.
We provide you with truly safe and effective solutions that match your risk profile, any available labs, and your explanation of health issues. Here are examples.
- Ivermectin / hydroxychloroquine
- Nattokinase and related kinases
- High dose vitamin C
- Methylene blue (we can ship beyond the U.S.)
- Light energy
- Other energy medicine approaches: sound, microcurrent, or hyperthermia
- Anti-inflammatory / anti-oxidative stress treatments
- General health recommendations
- Reversal of pre-existing conditions.
A peer-reviewed paper we published in 2020 explains some of the risk factors that exacerbate the effects of SARS-CoV-2 and, by reference, the "vaccine" jab.
The emergent outbreak of disease from SARS-CoV-2 (COVID-19) has caused a global pandemic. It highlights a need for a more proactive approach to medical diagnostics and care delivery since immunocompromised individuals and those with preexisting conditions are subject to extraordinarily high morbidity and mortality. Acute Respiratory Distress Syndrome (ARDS) and multiorgan dysfunction are among the leading causes of death in critically ill patients with COVID-19. Elevated inflammatory cytokines, noted in COVID-19 cases, suggest that a cytokine storm, also known as cytokine storm syndrome (CSS), may play a major role in the pathology of COVID-19. This pathway suggests a reaction by the innate immune system as the primary physiological defense mechanism against the virus.
Our emerging data indicate that those most vulnerable to mortality from COVID-19, including immunocompromised individuals and those with preexisting disease diagnoses, present with elevated cytokines at baseline. This burden likely contributes to adverse outcomes. Reactive treatments with immunosuppressant anti-inflammatories to reduce mortality from COVID-19-induced CSS is controversial but may offer a solution to reduce mortality from the latest stages of CSS. There is an urgent need for better risk characterization among populations during a pandemic to facilitate more targeted policy decisions based on vulnerability.
Novel proactive and reactive interventions to treat COVID-19-induced CSS, discussed here, may shorten the duration of any lockdown or requirement for social distancing. Here we discuss the pathogenesis of severe acute respiratory syndrome (SARS)-induced CSS, compare the CSS in COVID-19 with that in SARS and Middle East Respiratory Syndrome (MERS), and discuss physiological markers elevated in CSS. We illustrate interventions to mitigate risk on the early CSS continuum that function as “vaccines” for innate rather than adaptive immunity.
We propose a biphasic approach to moderate the severity of this and future viral-based pandemics. We also posit that the diagnostics and interventions used to mitigate pandemics may also be a model for a new healthcare approach when applied to measuring and reducing chronic disease burden and immunocompromised status. The approaches include measuring preexisting risk by accurately determining pre-cytokine storm status on a population basis, similar to measuring prediabetes to forestall diabetes. Part 2 is the reversal of pre-cytokine storm status, proactively, using a broad array of interventions.
We are experienced at reversing injuries and diseases.
Our team has published books, videos, blogs, and medical papers that explain our programs and results.
The titles of our key papers are: